Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease

Tri Pudy Asmarawati and Widodo and Mochammad Thaha and Aditiawardana and Nunuk Mardiana and Ardityo Rahmat Ardhany and Artaria Tjempakasari and Djoko Santoso and Pranawa and Chandra Irwanadi (2016) Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease. Acta Medica Indonesiana, 48 (1). pp. 28-34. ISSN 0125-9326

[img] Text (Artikel)
Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease.pdf

Download (305kB)
[img] Text (Peer Review)
Comparison of asymmetric.pdf

Download (1MB)
[img] Text (Similarity)
Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease.pdf

Download (2MB)
[img] Text (Bukti Korespondensi)
Kkorespondensi Comparison of Asymmetric.pdf

Download (90kB)
Official URL: http://www.actamedindones.org/index.php/ijim/artic...

Abstract

Aim: to determine the differences of ADMA level between stages 3, 4, and 5 non-dialysis of chronic kidney disease (CKD) patients at Outpatient Nephrology Clinic, Dr. Soetomo Hospital. Methods: a cross-sectional study was conducted on stage 3, 4, and 5 non-dialysis CKD patients at Outpatient Nephrology Clinic, Dr. Soetomo Hospital, Surabaya from January to February 2015. Stages of CKD were determined based on GFR estimation according to 4-variable MDRD formula. Statistical analysis of differences in the levels of ADMA in three subject groups use one-way ANOVA test. Results:seventy-five patients were included in the study. Each group consisted of 25 patients stage 3, 4, and, 5 non-dialysis patients. Mean age of stage 3, stage 4, and stage 5 non-dialysis CKD patients were respectively 57.12 years, 54.80 years and 53.68 years. The mean levels of ADMA in stage 3, stage 4, and 5 were 0.62 (0.11) IU/mL, 0.72 (0.16) IU/mL, and 0.73 (0.18) IU/mL respectively. Analysis of the differences between the groups showed significant differences in ADMA levels (p=0.04), with the highest difference between stage 3 and stage 5. Conclusion:comparison of ADMA levels showed significant differences between CKD stages and the level tends to be higher along with increase severity of CKD stages.

Item Type: Article
Uncontrolled Keywords: chronic kidney disease, asymmetric dimethylarginine (ADMA), cardiovascular disease
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
Divisions: 01. Fakultas Kedokteran > Ilmu Penyakit Dalam
Creators:
CreatorsNIM
Tri Pudy AsmarawatiNIDN0019108105
WidodoUNSPECIFIED
Mochammad ThahaNIDN0008057205
AditiawardanaNIDN8802800016
Nunuk MardianaNIDN8813800016
Ardityo Rahmat ArdhanyNIDN0013097704
Artaria TjempakasariNIDN8842800016
Djoko SantosoNIDN0726046101
PranawaUNSPECIFIED
Chandra IrwanadiUNSPECIFIED
Depositing User: arys fk
Date Deposited: 16 Feb 2021 02:22
Last Modified: 15 Jun 2021 02:57
URI: http://repository.unair.ac.id/id/eprint/103931
Sosial Share:

Actions (login required)

View Item View Item